Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950136-04-001419
Filing Date
2004-05-05
Accepted
2004-05-05 16:09:14
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A file001.htm 10-K/A 2432786
2 GRAPHIC ebox.gif GRAPHIC 112
3 GRAPHIC html_93433chart1.jpg GRAPHIC 60662
4 GRAPHIC spacer.gif GRAPHIC 90
5 GRAPHIC xbox.gif GRAPHIC 114
6 CONSENT OF ERNST & YOUNG LLP file002.htm EX-23.1 2896
7 CERTIFICATION file003.htm EX-31.1 8584
8 CERTIFICATION file004.htm EX-31.2 9711
9 WRITTEN STATEMENT OF THE CEO file005.htm EX-32.1 2438
10 WRITTEN STATEMENT OF THE CFO file006.htm EX-32.2 2448
  Complete submission text file 0000950136-04-001419.txt   2522452
Mailing Address FOUR SCIENCE PARK NEW HAVEN CT 06511
Business Address 4 SCIENCE PARK NEW HAVEN CT 06511 2034984210
VION PHARMACEUTICALS INC (Filer) CIK: 0000944522 (see all company filings)

EIN.: 133671221 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-26534 | Film No.: 04781738
SIC: 2836 Biological Products, (No Diagnostic Substances)